2Frenkel JK. Pneumocystis pneumonia, an immunodeficiency dependent disease (IDD): a critical historical overview[J]. J Eukaryot Microbiol, 1999,46(1) :89～92.
3Morris A, Lundgren JD,Masur H, et al. Current epidemiology of Pneumocystis pneumonia[J ]. Emerg Infect Dis, 2004, 10 (10): 1 713 ～ 1720.
4Fisk DT, Meshnick S, Kazanjian PH , et al. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome[J].Clin Infect Dis,2003,36(1) :70～ 78.
5Kim JM, Cho JG, Hong SK, et al. Epidemiology and clinical features of HIV infection/AIDS in Korea[J]. Yonsei Med J, 2003, 44(3):363～370.
10Masur H, Kaplan JE, Holmes KK, et al. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U. S. Public Health Service and the Infectious Diseases Society of America[J].Ann Intern Med, 2002,137(5 Pt 2):435～478.
7Crowe SM, Carlin JB, Stewart KI, et al. Predictive value of CD4^+ lymphocyte numbers for the devlopment of opportunistic infections and malignsnces in HIV-infected persons[J]. J Acquir Immune Defic Syndr, 1991, 4:770- 776.
8Perriens JH, Colebunders RL, Karahunga C, et al. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "Standard" chemotherapy in Kinshasa, Zaire[J]. Am Rev Respir Dis, 1991,144:750 - 755.
9Phair J, Mhnoz A, Detels R, et al. The risk of pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I[J]. N Engl J Med, 1990, 322:161-165.
